Drug Shortage Report for CEFAZOLIN IN DEXTROSE INJECTION, USP
| Report ID | 254442 |
| Drug Identification Number | 02496313 |
| Brand name | CEFAZOLIN INJECTION, USP |
| Common or Proper name | Cefazolin Injection USP 1000 mg / 50 mL |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFAZOLIN |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | CA2G3503– 24 bags/case |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2025-06-14 |
| Actual start date | 2025-06-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-19 |
| Company comments | The root cause is a shortage of active pharmaceutical ingredients (API). Foreign authorized supply is available. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2025-11-19 | French | Compare |
| v13 | 2025-11-19 | English | Compare |
| v14 | 2025-11-19 | English | Compare |
| v12 | 2025-11-18 | English | Compare |
| v11 | 2025-11-18 | French | Compare |
| v10 | 2025-11-18 | English | Compare |
| v9 | 2025-07-23 | French | Compare |
| v8 | 2025-07-23 | English | Compare |
| v7 | 2025-06-15 | English | Compare |
| v5 | 2025-05-30 | French | Compare |
| v6 | 2025-05-30 | French | Compare |
| v4 | 2025-05-30 | English | Compare |
| v3 | 2025-04-07 | French | Compare |
| v2 | 2025-04-07 | English | Compare |
| v1 | 2025-04-07 | English | Compare |
Showing 1 to 15 of 15